REHOVOT, Israel , April 2, 2007 (PRIME NEWSWIRE) -- Rosetta Genomics, Ltd. (Nasdaq:ROSG) announced today that it has presented data on its newly developed high quality microRNA extraction protocol from blood serum. The data was presented at Cambridge Healthtech Institute’s microRNA in Human Disease and Development Conference, held March 29-31, 2007 in Boston, MA.
